In the podcast we hear from Ellen, whose strong family history of breast and ovarian cancer led her to make the hard, controversial decision to undergo multiple prophylactic surgeries years before genetic testing would become available. After losing her own mother at a young age from breast cancer, Ellen wanted to make sure she did…

Read More

Update: The American College of Obstetricians and Gynecologists (ACOG) recently published a committee opinion for women of population risk to develop ovarian cancer. ACOG recommends that average-risk women who are having gynecological surgery (such as removal of their uterus (hysterectomy) or having their tubes tied (tubal ligation) be counseled about the option of having their fallopian tubes removed (salpingectomy) at…

Read More

It is well-known that women who carry a mutation in BRCA1 or BRCA2 are at high risk to develop both breast (50-85% lifetime risk) and ovarian (15-60% lifetime risk) cancer. Because the screening options for ovarian cancer (transvaginal ultrasound, the blood test CA-125 and physical exam), are not effective at finding ovarian cancers at earlier,…

Read More